Kenneth Stauderman
Founder at CALCIMEDICA, INC.
Net worth: 67 842 $ as of 30/05/2024
Profile
Kenneth A.
Stauderman is the founder.
He founded CalciMedica, Inc. (US) in 2006 and CalciMedica, Inc. in 2007, where he holds the title of Chief Scientific Officer.
Dr. Stauderman's former jobs include being the Director-Olecular & Cell Biology at Sibia Neurosciences, Inc. from 1994 to 2000, Executive Director-Biology & Lead Discovery at TorreyPines Therapeutics, Inc. from 2000 to 2007, and Senior Scientist at Sanofi-Aventis U.S.
LLC from 1986 to 1994.
He also worked at Marion Merrell Dow Pharmaceutical, Inc. as a Senior Scientist.
Dr. Stauderman's education history includes an undergraduate degree from the University of Virginia and a doctorate degree from the Texas University of Health Center at San Antonio.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CALCIMEDICA, INC.
0.11% | 30/03/2024 | 11,944 ( 0.11% ) | 67 842 $ | 30/05/2024 |
Kenneth Stauderman active positions
| Companies | Position | Start |
|---|---|---|
| CALCIMEDICA, INC. | Founder | 31/03/2007 |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Founder | 10/08/2009 |
Former positions of Kenneth Stauderman
| Companies | Position | End |
|---|---|---|
TorreyPines Therapeutics, Inc.
 TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Corporate Officer/Principal | 31/12/2006 |
| Sibia Neurosciences, Inc. | Corporate Officer/Principal | 31/12/1999 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 31/12/1993 |
| Marion Merrell Dow Pharmaceutical, Inc. | Chief Tech/Sci/R&D Officer | - |
Training of Kenneth Stauderman
| University of Virginia | Undergraduate Degree |
| Texas University of Health Center at San Antonio | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CALCIMEDICA, INC. | Health Technology |
| Private companies | 5 |
|---|---|
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Health Technology |
| Sibia Neurosciences, Inc. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
| Marion Merrell Dow Pharmaceutical, Inc. |
- Stock Market
- Insiders
- Kenneth Stauderman